{"id":233350,"date":"2026-04-20T10:32:00","date_gmt":"2026-04-20T14:32:00","guid":{"rendered":"https:\/\/news-you-need.com\/index.php\/2026\/04\/20\/lilly-adds-gene-delivery-technology-to-car-t-in-up-to-7b-kelonia-deal\/"},"modified":"2026-04-20T10:40:26","modified_gmt":"2026-04-20T14:40:26","slug":"lilly-adds-gene-delivery-technology-to-car-t-in-up-to-7b-kelonia-deal","status":"publish","type":"post","link":"https:\/\/news-you-need.com\/index.php\/2026\/04\/20\/lilly-adds-gene-delivery-technology-to-car-t-in-up-to-7b-kelonia-deal\/","title":{"rendered":"Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal"},"content":{"rendered":"<p><a href=\"https:\/\/www.biospace.com\/business\/lilly-adds-gene-delivery-technology-to-car-t-in-up-to-7b-kelonia-deal\">Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal<\/a><\/p>\n<p><a href=\"https:\/\/www.biospace.com\/business\/lilly-adds-gene-delivery-technology-to-car-t-in-up-to-7b-kelonia-deal\">https:\/\/www.biospace.com\/business\/lilly-adds-gene-delivery-technology-to-car-t-in-up-to-7b-kelonia-deal<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-04-20 10:32:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.biospace.com\">www.biospace.com<\/a><\/p>\n<p>After getting a taste of CAR T in February, Eli Lilly is doubling down with the up to $7 billion acquisition of gene delivery biotech Kelonia Therapeutics.<\/p>\n<p>Lilly snags a Phase 1 lentiviral in vivo CAR-T therapy called KLN-1010 in the deal, however the real prize is Kelonia\u2019s in vivo gene delivery and integration technology, called iGPS. The platform uses lentiviral-based particles to deliver T-cells, at which point the patient\u2019s body takes over and generates its own CAR T therapies. The goal is to eliminate the need for complex manufacturing processes and pre-treatment chemotherapy.<\/p>\n<p>Kelonia will add to Lilly\u2019s current capabilities in the space and allow the application of the delivery technology to other conditions, Jacob Van Naarden, president of Lilly Oncology and head of corporate business development, said in a <span class=\"LinkEnhancement\">statement<\/span>.<\/p>\n<p>The Kelonia deal had been rumored over the weekend after a <span class=\"LinkEnhancement\">report in Reuters<\/span>. Commenting on the potential transaction in a Sunday note, BMO Capital Markets suggested that Lilly was \u201cjumping into in vivo CAR-T with both feet.\u201d<\/p>\n<p>\n        After a flurry of deals over the past week from Eli Lilly, Merck and Biogen, analysts predict more M&#038;A action from other big names, including Novartis, Amgen and AbbVie.\n    <\/p>\n<p>April 3, 2026<\/p>\n<p><span class=\"dot\">\u00a0\u00b7\u00a0<\/span><\/p>\n<p>3 min read<\/p>\n<p><span class=\"dot\">\u00a0\u00b7\u00a0<\/span><\/p>\n<p>The deal \u201cwould add a complementary in vivo approach that could broaden Lilly\u2019s push to build oncology beyond small molecules and antibodies. Aiding in efforts to drive durable growth beyond metabolic,\u201d the analysts&#8230;<\/p>\n<p><a href=\"https:\/\/www.biospace.com\/business\/lilly-adds-gene-delivery-technology-to-car-t-in-up-to-7b-kelonia-deal\">Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal https:\/\/www.biospace.com\/business\/lilly-adds-gene-delivery-technology-to-car-t-in-up-to-7b-kelonia-deal&#8230;<\/p>\n","protected":false},"author":1,"featured_media":233351,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/static.biospace.com\/dims4\/default\/371ce13\/2147483647\/strip\/true\/crop\/4913x2764+0+220\/resize\/1440x810!\/quality\/90\/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F78%2F2c%2F86646dd94615ade070ba95371b37%2Fistock-2153331201-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[8],"tags":[87,85],"class_list":["post-233350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-automotive","tag-space"],"_links":{"self":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/233350"}],"collection":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=233350"}],"version-history":[{"count":1,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/233350\/revisions"}],"predecessor-version":[{"id":233352,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/233350\/revisions\/233352"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/233351"}],"wp:attachment":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=233350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=233350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=233350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}